Apellis Pharmaceuticals, Inc.
(NASDAQ : APLS)

( )
APLS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 1.46%38.340.9%$1224.56m
JNJJohnson & Johnson 1.80%149.620.7%$883.79m
MRKMerck & Co., Inc. 2.26%82.740.7%$648.59m
BMYBristol-Myers Squibb Co. 0.81%63.641.0%$648.38m
ABBVAbbVie, Inc. 3.11%95.551.9%$626.64m
AZNAstraZeneca Plc 2.85%56.751.2%$571.06m
LLYEli Lilly & Co. 1.32%152.621.1%$419.73m
NVSNovartis AG 3.02%84.920.2%$146.41m
GSKGlaxoSmithKline Plc 2.12%42.170.2%$139.29m
MISTMilestone Pharmaceuticals, Inc. -1.12%8.800.0%$120.75m
OPKOPKO Health, Inc. -5.03%4.7211.2%$111.10m
NVONovo Nordisk A/S 2.92%67.090.1%$72.27m
RGENRepligen Corp. 0.66%142.937.2%$67.22m
PRNBPrincipia Biopharma, Inc. 3.78%87.340.0%$58.45m
SNYSanofi 1.91%51.790.2%$57.22m

Company Profile

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.